204 results on '"Testani, Jeffrey M."'
Search Results
2. Sodium zirconium cyclosilicate in patients with HFrEF and hyperkalemia: REALIZE-K rationale, design, and baseline characteristics
3. Serial direct sodium removal in patients with heart failure and diuretic resistance
4. The salt paradox in heart failure
5. Kidney and heart failure events are bidirectionally associated in patients with type 2 diabetes and cardiovascular disease
6. Empagliflozin in Heart Failure: Regional Nephron Sodium Handling Effects
7. Abstract 17773: Novel Partition Scores Identify Pathways Implicated in Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mediated Heart Failure
8. Outcomes Associated with Sodium-Glucose Cotransporter-2 Inhibitor Use in Acute Heart Failure Hospitalizations Complicated by Acute Kidney Injury
9. Congestion and Decongestion Assessment in Heart Failure
10. Effect of Sotagliflozin on Early Mortality and Heart Failure-Related Events
11. Randomized controlled trial of urinE chemiStry guided aCute heArt faiLure treATmEnt (ESCALATE): Rationale and design
12. Perirenal Adipose Tissue Is Associated With Renal Dysfunction and Abnormal Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction
13. Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
14. Association of Urine Galectin-3 With Cardiorenal Outcomes in Patients With Heart Failure
15. SGLT2 inhibitors and Diuretics in Heart Failure: Clicking Reset on the Renal Volume Setpoint?
16. A randomized clinical trial assessing the effect of automated medication-targeted alerts on acute kidney injury outcomes
17. “Pouring Salt in the Wound” of Sodium Restriction in Acute Heart Failure
18. Updates in Cardiorenal Syndrome
19. The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial
20. Changes in the Inferior Vena Cava Are More Sensitive Than Venous Pressure During Fluid Removal: A Proof-of-Concept Study
21. In-Hospital Observation on Oral Diuretics After Treatment for Acute Decompensated Heart Failure: Evaluating the Utility
22. Loop Diuretic Resistance in a Patient with Acute Heart Failure
23. Risk stratification of patients listed for heart transplantation while supported with extracorporeal membrane oxygenation
24. Improvement in Renal Function During the Treatment of Acute Decompensated Heart Failure: Relationship With Markers of Renal Tubular Injury and Prognostic Importance
25. The Reply
26. Rates of In-Hospital Decongestion and Association with Mortality and Cardiovascular Outcomes Among Patients Admitted for Acute Heart Failure
27. “Dip” in eGFR: Stay the Course With SGLT-2 Inhibition
28. Rates of Reversal of Volume Overload in Hospitalized Acute Heart Failure: Association With Long-term Kidney Function
29. List of Contributors
30. Animal Models for Cardiovascular Research
31. Hemoconcentration of Creatinine Minimally Contributes to Changes in Creatinine during the Treatment of Decompensated Heart Failure
32. Renin-Angiotensin-Aldosterone System Activation and Diuretic Response in Ambulatory Patients With Heart Failure
33. Classic and Novel Mechanisms of Diuretic Resistance in Cardiorenal Syndrome
34. 248 Use of a Propensity Score to Examine Association between Rates of In-Hospital Decongestion and Mortality and Cardiovascular Outcomes Among Patients admitted for Acute Heart Failure
35. Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology
36. Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure
37. NATRIURESIS IS LOWER IN BLACK PATIENTS WITH ACUTE HEART FAILURE: A POST HOC ANALYSIS OF ROSE-AHF
38. Mortality after acute kidney injury and acute interstitial nephritis in patients prescribed immune checkpoint inhibitor therapy
39. Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease
40. Changes in inferior vena cava area represent a more sensitive metric than changes in filling pressures during experimental manipulation of intravascular volume and tone
41. Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience
42. FGF-23 (Fibroblast Growth Factor-23) and Cardiorenal Interactions
43. Renal negative pressure treatment as a novel therapy for heart failure-induced renal dysfunction
44. Compensatory post-diuretic renal sodium reabsorption is not a dominant mechanism of diuretic resistance in acute heart failure
45. Early diuretic strategies and the association with In-hospital and Post-discharge outcomes in acute heart failure
46. Acute Kidney Injury in the Era of Ventricular Assist Devices
47. Improving renal function during diuresis: useful information or just noise?
48. Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure: Racial Differences and a Potential for Reducing Disparities
49. Reply
50. Pragmatic Design of Randomized Clinical Trials for Heart Failure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.